Life Steps for PrEP for Youth

NCT03805451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-03-22

No results posted yet for this study

Summary

This is a formative study, designed to provide information required to tailor Life-Steps for Pre-Exposure Prophylaxis (PrEP), an evidence-based cognitive behavioral adherence intervention, to enhance PrEP uptake and adherence in high risk young men who have sex with men (YMSM) and young transgender women who have sex with men (YTWSM).

Life-Steps for Pre-exposure prophylaxis (PrEP) is a manualized modular adherence intervention based on principles of cognitive-behavioral therapy (CBT), that allows for recipients of the intervention to focus on the greatest challenges that they perceive in maintaining optimal adherence to PrEP.

Conditions

  • HIV
  • Pre-exposure Prophylaxis
  • Medication Adherence

Interventions

BEHAVIORAL

Life Steps for PrEP for Youth

Life-Steps is a modular adherence intervention based on principles of cognitive-behavioral therapy (CBT), that allows for recipients of the intervention to focus on the greatest challenges that they perceive in maintaining optimal adherence to pre-exposure prophylaxis.

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER
  • University of North Carolina

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • Brown University

    collaborator OTHER
  • Cook County Hospital

    collaborator OTHER
  • Fenway Community Health

    lead OTHER

Principal Investigators

  • Ken A Mayer, MD · The Fenway Institute

  • Christina Psaros, Ph.D. · Harvard Medical School and Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-27
Primary Completion
2022-05-31
Completion
2022-11-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03805451 on ClinicalTrials.gov